Evaluation of Vancomycin in Combination with Piperacillin-Tazobactam or Oxacillin against Clinical Methicillin-Resistant Staphylococcus aureus Isolates and Vancomycin-Intermediate S. aureus Isolates In Vitro

Vancomycin with piperacillin-tazobactam is used as empirical therapy for critically ill patients. Studies of this combination against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-intermediate S. aureus (VISA) are limited, but β-lactams in combination with vancomycin have shown s...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Dilworth, Thomas J., Sliwinski, Jora, Ryan, Keenan, Dodd, Monique, Mercier, Renée-Claude
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2014
Témata:
Susceptibility
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3910859/
https://ncbi.nlm.nih.gov/pubmed/24277036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01888-13
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky